Bellerophon Therapeutics, Inc. Gains 37.21%

Wed, Jan 10, 2024 at 07:33 PM
Bellerophon Therapeutics, Inc. Gains 37.21%

Bellerophon Therapeutics, Inc. (BLPH:NASDAQ) jumped higher at $0.06, representing a gain of 37.2%. On Wed, Jan 10, 2024, BLPH:NASDAQ hit a New 2-Week High of $0.06. From Wed, Dec 27, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days

About Bellerophon Therapeutics, Inc. (BLPH:NASDAQ)

Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. It develops products that are focused on the treatment of various types of pulmonary hypertension disorder.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.